Amyotrophic lateral sclerosis is a fatal CNS neurodegenerative disease. Despite intensive
research, current management of amyotrophic lateral sclerosis remains suboptimal from …

Background Sodium phenylbutyrate and taurursodiol have been found to reduce neuronal
death in experimental models. The efficacy and safety of a combination of the two compounds …

Amyotrophic lateral sclerosis is a fatal neurodegenerative disease. The discovery of genes
associated with amyotrophic lateral sclerosis, commencing with SOD1 in 1993, started fairly …

Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling
complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of the motor
neurons, which results in weakness and atrophy of voluntary skeletal muscles. Treatments …

An orally administered, fixed‐dose coformulation of sodium phenylbutyrate‐taurursodiol (PB‐TURSO)
significantly slowed functional decline in a randomized, placebo‐controlled, …

Importance Amyotrophic lateral sclerosis (ALS) has an immune component, but previous
human studies have not examined immune changes over time. Objectives To assess …

Importance Persistent environmental pollutants may represent a modifiable risk factor involved
in the gene-time-environment hypothesis in amyotrophic lateral sclerosis (ALS). Objective …

The diagnosis of amyotrophic lateral sclerosis can be challenging due to its heterogeneity
in clinical presentation and overlap with other neurological disorders. Diagnosis early in the …

Importance Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
of the motor nervous system. Clinical studies have demonstrated cortical and spinal motor …